Stock listing
Bcal Diagnostics Limited
Selected listing: BDX · ASX · AUD · AU
Bcal Diagnostics Limited (ASX:BDX), Health Services. Latest release Sep 29, 2026: BREASTESTplus 2 clinically validated.
- Ticker
- ASX:BDX
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- ASX
- Currency
- AUD
About Bcal Diagnostics Limited
Bcal Diagnostics Limited, trading under the ticker BDX, is a public company listed on the Australian market. Bcal Diagnostics focuses on innovative solutions in the diagnostics sector.
Latest news from Bcal Diagnostics Limited
BREASTESTplus 2 clinically validated
September 29, 2026
BCAL Introduces Avantect Multi-Cancer Early Detection Test
September 22, 2026
Appendix 4E and Annual Report to shareholders
August 28, 2026
BCAL Takes Interest in Genetic Signatures to 18.46%
August 25, 2026
BCAL Secures Funding for FY2027 Update
August 21, 2026
Research Bcal Diagnostics Limited
Bcal Diagnostics Limited company profile
View the public company page for Bcal Diagnostics Limited on 6ix.
Bcal Diagnostics Limited news
Read company news and market updates connected to Bcal Diagnostics Limited.
Bcal Diagnostics Limited investor events
Find investor webinars, events, and replay context for Bcal Diagnostics Limited.